budesonide/formoterol / Generic mfg. |
NCT00651651: Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 80/4.5 |
|
|
| Completed | 3 | 450 | US | budesonide/formoterol, Symbicort, budesonide, formoterol | AstraZeneca | Asthma | | 09/03 | | |
NCT00652002: Efficacy of Symbicort Versus Its Monocomponents - SPRUCE 160/4.5 |
|
|
| Completed | 3 | 450 | US | budesonide/formoterol, Symbicort, budesonide, formoterol | AstraZeneca | Asthma | | 01/04 | | |
NCT00652392: Efficacy of Symbicort pMDI Administered Once Daily in Adolescents and Adults During 12 Weeks - STEM |
|
|
| Completed | 3 | 750 | US | budesonide/formoterol, Symbicort, budesonide and placebo | AstraZeneca | Asthma | | 06/04 | | |
NCT00646321: Efficacy of Symbicort pMDI Administered Once Daily in Children and Adolescents During 12 Weeks - SPROUT |
|
|
| Completed | 3 | 540 | US | budesonide/formoterol (Symbicort), Symbicort, budesonide | AstraZeneca | Asthma | | 08/04 | | |
NCT00651768: Titratable Dosing in Moderate to Severe Asthmatics |
|
|
| Completed | 3 | 570 | US | budesonide/formoterol, Symbicort, Symbicort pMDI + budesonide HFA pMDI | AstraZeneca | Asthma | | 01/05 | | |
| Completed | 3 | 1200 | US | budesonide/formoterol (Symbicort), Symbicort, fluticasone/salmeterol (Advair), Advair | AstraZeneca | Asthma | | 01/05 | | |
SYMPHONIE, NCT00259792: - A Comparison of Symbicort Single Inhaler and Conventional Best Practice for the Treatment of Persistent Asthma in Adolescents and Adults |
|
|
| Completed | 3 | 1000 | Europe | Budesonide/formoterol Turbuhaler, Symbicort | AstraZeneca | Asthma | | 01/06 | | |
| Completed | 3 | 16 | Europe | formoterol, budesonide/formoterol | AstraZeneca | Asthma | | 05/06 | | |
NCT00242775 / 2004-004905-11: Comparison of the Efficacy/Safety of Symbicort® Turbuhaler®,Seretide™ Diskus™ 50/500 µg & Terbutaline Turbuhaler® 0.4 mg |
|
|
| Completed | 3 | 2100 | Canada, Europe, RoW | Budesonide/formoterol Turbuhaler, Symbicort, Salmeterol/fluticasone Diskus | AstraZeneca | Asthma | | 05/06 | | |
| Completed | 3 | 1000 | Europe | Budesonide/formoterol, Symbicort | AstraZeneca | Asthma | | 08/06 | | |
NCT00235911: Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting |
|
|
| Completed | 3 | 100 | Europe | budesonide/formoterol Turbuhaler | AstraZeneca | Asthma | 10/06 | 12/06 | | |
NCT00252785: Efficacy & Safety of Symbicort® TURBUHALER® 160/4.5 µg Twice Daily & Pulmicort® TURBUHALER® 200 µg Twice Daily + Theolong® Tablet 200 mg Twice Daily in Japanese Asthmatic Patients |
|
|
| Completed | 3 | 340 | Japan | Budesonide/Formoterol, Symbicort, Budesonide, Theophylline | AstraZeneca | Asthma | | 11/06 | | |
| Completed | 3 | 1000 | Europe, RoW | Budesonide/formoterol Turbuhaler vs Conventional Best Asthma Therapy, Symbicort | AstraZeneca | Asthma | | 12/06 | | |
NCT00255255: Safety & Efficacy of Symbicort® Turbuhaler® (1, 2, and 4 x 160/4.5 µg Twice Daily) in Japanese Patients With Asthma |
|
|
| Completed | 3 | 120 | Japan | Budesonide/Formoterol, Symbicort | AstraZeneca | Asthma | 12/06 | 06/07 | | |
NCT00244608 / 2004-004042-41: A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler® |
|
|
| Completed | 3 | 100 | Europe | Budesonide/Formoterol Turbuhaler, Symbicort, Budesonide Turbuhaler (Pulmicort), Terbutaline Turbuhaler | AstraZeneca | Asthma | | 03/07 | | |
NCT00259766: SHARE - Symbicort and Health Economics in a Real Life Evaluation |
|
|
| Completed | 3 | 1970 | Europe | Budesonide, Symbicort, Formoterol, Terbutaline | AstraZeneca | Asthma | | 05/07 | | |
| Completed | 3 | 600 | Canada | Budesonide/formoterol, Symbicort | AstraZeneca | Asthma | | 05/07 | | |
NCT00449527: A Two-week Study Assessing the Onset of Effect Questionnaire (OEQ) Administered Daily Versus Weekly in Adult Subjects |
|
|
| Completed | 3 | 123 | US | Budesonide/formoterol pMDI, Symbicort, Budesonide HFA pMDI | AstraZeneca | Asthma | | 08/07 | | |
NCT00449501: A Two-week Study Assessing the Onset of Effect Questionnaire Administered Pre-dose Versus Post-dose in Adult Subjects |
|
|
| Completed | 3 | 134 | US | Budesonide/formoterol pMDI, Symbicort, Budesonide HFA pMDI | AstraZeneca | Asthma | | 11/07 | | |
| Completed | 3 | 107 | Europe, RoW | Budesonide/formoterol pMDI 40/2.25ug + spacer, Budesonide/formoterol pMDI 40/2.25 ug | AstraZeneca | Asthma | 02/08 | 02/08 | | |
| Completed | 3 | 742 | Europe | Symbicort Turbuhaler, Symbicort pMDI, Pulmicort Turbuhaler | AstraZeneca | Bronchial Asthma | 04/08 | 04/08 | | |
NCT00419757: An Efficacy Study Comparing SYMBICORT® Pressurised Metered Dose Inhaler (pMDI) With Budesonide Hydrofluoroalkanes (HFA) pMDI, in Hispanic Subjects With ICS Dependent Asthma |
|
|
| Completed | 3 | 558 | US | Budesonide/formoterol (SYMBICORT) pMDI, Budesonide HFA pMDI | AstraZeneca | Asthma | 06/08 | 06/08 | | |
PASSION, NCT00628758: A Comparison of Symbicort® Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma |
|
|
| Completed | 3 | 430 | RoW | Symbicort TBH - Turbuhaler, beta-II-agonist, inhale steroid, Astmerol inh 25 mcg/dosage, 60-120 dosage, Astmerol maksihaler 50 mcg/dosage, 28-60 dosage, Serevent diskus 50 mcg/dosage, 60 dosage, Serevent inh 25 mcg/dosage, 60 dosage, Foradil inh kap 12 mcg/dosage, 60 caps, Foradil inh 12 mcg/dosage, 50-100 dosage, Foradil combi 200 mcg, Foradil combi 400 mcg, Oxis turbuhaler 4.5-9 mcg/dosage, 60 dosage, Ventofor 12mg/60 inh.caps, Seretide disc 100-250-500 mcg/dosage 60 dosage, Symbicort 160/4.5 mcg/60-120 dosage, 320/9mcg/60 dosage | AstraZeneca | Asthma | 09/08 | 09/08 | | |
| Terminated | 3 | 654 | Europe | Symbicort (budesonide/formoterol) Turbuhaler, Conventional treatment | AstraZeneca | Asthma, Bronchial | | 10/08 | | |
NCT00837967: Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients |
|
|
| Completed | 3 | 25 | Japan | Symbicort Turbuhaler, Terbutaline Turbuhaler | AstraZeneca | Asthma | 07/09 | 07/09 | | |
NCT00419952: A Comparison of SYMBICORT® pMDI With Budesonide HFA pMDI in African American Subjects With Asthma. |
|
|
| Completed | 3 | 742 | US | Budesonide/formoterol (SYMBICORT) pMDI, Budesonide HFA pMDI | AstraZeneca | Asthma | 11/09 | 11/09 | | |
NCT01099722 / 2009-017223-25: Assessment of the Efficacy and Safety of FlutiForm® pMDI 125/5 µg (2 Puffs Bid) Versus Symbicort® Turbohaler® 200/6 µg (2 Puffs Bid) in Adolescent and Adult Subjects With Moderate to Severe Persistent, Reversible Asthma |
|
|
| Completed | 3 | 261 | Europe, RoW | Flutiform, Symbicort Turbohaler | Mundipharma Research Limited | Asthma | 11/10 | 07/11 | | |
| Completed | 3 | 2091 | Japan, Europe, RoW | Symbicort Turbuhaler, Terbutaline Turbuhaler | AstraZeneca | Asthma | 02/11 | 02/11 | | |
| Completed | 3 | 12460 | Europe, US, RoW | Symbicort pMDI, budesonide pMDI | AstraZeneca | Asthma | 10/15 | 10/15 | | |
CHASE 3, NCT02091986 / 2013-005293-22: A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg |
|
|
| Completed | 3 | 882 | US, Europe, RoW | Symbicort pMDI, Budesonide pMDI, Active comparator | AstraZeneca | Asthma | 04/16 | 04/16 | | |
NCT02725242: Efficacy of Once-daily Budesonide/Formoterol Turbuhaler 4.5/160 µg in Step Down Asthma |
|
|
| Completed | 3 | 77 | RoW | Budesonide/formoterol (160/4.5 μg/d), Symbicort Turbuhaler (160/4.5 μg/d), Budesonide (400μg/d), Giona Easyhaler | Hat Yai Medical Education Center | Asthma | 12/16 | 12/16 | | |